Member Info for Mozax

Paid.

Looks like a tug of war between the 100K buyer & 93K seller……very weird!!

L2, 5.3 sell, 6.0 Buy……..try buying lol!!!

NT, can’t buy.

Interestingly, approx 100K of buys and the MM’s have just widened the spread, trying to put off buyers.

Stock is very tight here as traders have traded & real investors can see the longer term huge opportunity here.

Oh yes, big trades showing now, 2.5M ….at 54.5

Circa 19M traded today.

This seems to be attracting greater volume, presumably newcomers will hold at these low prices thus creating tighter freefloat.

Views?

This will move up quickly with a bit of buying pressure, looks set to go if our 100K buyer gets going again.

£10.5M plus Royalties from this deal within the next few months.

Oh yes, plus £160M plus Royalties from the recent RNS.

£9M in cash.

Plus a lot in the pipeline.

MCap £13.75M.

Lol.

Yes, I’m continuing to add also, slowly building a very large holding.
It’s quite something to have a mega deal in the bag, with plenty more coming down the line before the really big lumps of cash starts rolling in.

£13M MCap with £9M in cash in the bank, and all the work already behind them.

Great BoD too.

This is a gift.

And someone has woken up this morning and bought £10K of stock, so cheap down here atm.

Hi Cattleman, it was aired on Dir3ctorstalk ( if I put the e in the word it won’t post, so substitute the asterisk for the above) on the 15th September 2022.

https://www.*************.com/n4-pharma-plans-for-commercialising-nuvec-video/4121082366

It was a great update and Nigel oozing confidence.

In addition, BBC World News today aired a great interview with the BioNTech founders who explained the ‘Huge amount’ of work going into MRNA /siRNA and the potential in the race to find a cure for Cancer.

Hi Cattleman, it was aired on Dir3ctorstalk ( if I put the e in the word it won’t post, so substitute the asterisk for the above) on the 15th September 2022.

https://www.*************.com/n4-pharma-plans-for-commercialising-nuvec-video/4121082366

It was a great update and Nigel oozing confidence.

In addition, BBC World News today aired a great interview with the BioNTech founders who explained the ‘Huge amount’ of work going into MRNA /siRNA and the potential in the race to find a cure for Cancer.

Let’s see if the buying continues this morning, profits taken from the lows & consolidated, now for the next leg up, as we know, this moves very quickly.

Undervalued at 10p a share, so let’s see where this goes.

I’ve watched the last 2 presentations, the one posted 2 months ago and lasts 40 mins is particularly revealing, with a great deal of information.

There’s going to be a great deal of news-flow across a number of indications over the next months.

And if the Company can announce an almost out of the blue $160M deal plus double digit Royalties in an area they weren’t necessarily focussing on.
Think what may be achieved in the areas currently in trials, and what Global rights may be licensed to other Pharmaceutical Companies.

There’s a lot going on here, and clearly their Sulforaphane-based medicine is pretty special.

Yes, a 20p target in the short term, but there’s also a great deal in the pipeline.

The next deal could come along at any time.

Lock them away.

Oh yes, and no debt.

Also interesting to note that The Equans Belux sale announced yesterday progressed from Advanced directly to Closed, so is additional to their ‘Base’ sales pipeline of 22MWh, nearing sales Completion.

I sense a huge surge of interest in Vanadium Flow Batteries, and Invinity, A Global leader, is well placed to do extremely well.

This will be the absolute Game Changer for Invinity.

50 MWh…..100Mwh Vanadium Flow Batteries on a scale never seen before.

Invinity have already invested heavily in this, in funding, time & manpower, and it hasn’t been priced in yet.

In fact, with £16 Million in cash, a solid order book, both short & medium term, and £12.8M in Sales Inventory about to leave the Factory nothing has been priced in!!!

Current MCap is £32M. Talk about very seriously undervalued.

And this is Utility Grade Energy Storage, just what the whole World needs.

With only 116M Shares in issue a share Price of 100p puts the MCap at a Paltry £116M, and as even more interest & forward orders start to get notched up for “Project Mistral” imagine where this could go then.

At 5/6/7p makes no difference when the intention is to hold for 12 plus months.

The key is to accumulate a decent holding, then switch off.

500K shares may cost circa £30K now, but I suspect will be worth many multiples in 12 months.

Pop them in the ISA for Tax free gains.